Clinical Trial Update: Study of Cetuximab to Treat Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cetuximab for gastric cancer conducted by Fudan University has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: Fudan University | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED